Lilly USA, LLC

Pharmaceuticals

Based in IN

🤖

AI Overview

With $1.5M in lobbying spend across 23 quarterly filings, Lilly USA, LLC is a significant lobbying presence. They deploy 18 individual lobbyists

$1.5M
Total Lobbying Spend
23
Quarterly Filings
1
Lobbying Firms Used
18
Individual Lobbyists

Spending by Year

YearLobbying Spend
2019$30K
2020$230K
2021$240K
2022$180K
2023$240K
2024$250K
2025$360K

Lobbying Firms

BROWNSTEIN HYATT FARBER SCHRECK, LLP

What They Lobby For

  • Issues related to the pharmaceutical industry
  • Issues related to the pharmaceutical industry HR 748 CARES Act - Issues related to COVID-19 relief
  • Issues related to the pharmaceutical industry Issues related to COVID-19 relief
  • Issues related to the pharmaceutical industry Issues related to COVID-19 relief H.R.133 - Consolidated Appropriations Act, 2021
  • Issues related to the pharmaceutical industry, Issues related to COVID-19 relief H.R.1319 - American Rescue Plan Act of 2021
  • Issues related to the pharmaceutical industry, Issues related to COVID-19 relief
  • Issues related to the pharmaceutical industry, Issues related to COVID-19 relief H.R.3684 - Infrastructure Investment and Jobs Act
  • Issues related to the pharmaceutical industry, Issues related to COVID-19 relief H.R.3684 - Infrastructure Investment and Jobs Act H.R.5376 - Build Back Better Act
  • Issues related to the pharmaceutical industry, Issues related to COVID-19 relief H.R.3684 - Infrastructure Investment and Jobs Act H.R.5376 - Build Back Better Act
  • Issues related to the pharmaceutical industry Issues related to COVID-19 relief H.R. 5376 - Build Back Better Act

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.